Yanqing Zhang

机构：Beijing Institute of Technology, Nvidia (United Kingdom), Guangxi University, Hubei University of Science and Technology, University of Hong Kong - Shenzhen Hospital, Southern Medical University Shenzhen Hospital, Henan Cancer Hospital, The First People's Hospital of Xiaoshan District, Hangzhou · ORCID：0000-0003-0156-699X

发表论文 31 篇 · 总被引 234 次 · h-index 7

代表论文

• lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia (2017 · International Journal of Molecular Medicine · 被引 57)
• Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma (2017 · Oncology Letters · 被引 52)
• Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma (2018 · Oncology Reports · 被引 36)
• The maintenance of modified electroconvulsive therapy combined with risperidone is better than risperidone alone in preventing relapse of schizophrenia and improving cognitive function (2016 · Arquivos de Neuro-Psiquiatria · 被引 25)
• A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy (2024 · Blood · 被引 9)
• Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study (2024 · Clinical Lymphoma Myeloma & Leukemia · 被引 9)